Reduced inositol-dependent signalling was the first proposed mechanism for bipolar disorder treatments [54,93], primarily based on a lithium-induced attenuation of inositol recycling through inhibition of inositol monophophatase (IMPase) and inositol polyphosphate 1-phosphatase (IPPase) [94]. The gene discussed is INPP1; the disease is bipolar disorder.